Medifast
MED
#8957
Rank
A$0.20 B
Marketcap
A$18.40
Share price
1.00%
Change (1 day)
-35.64%
Change (1 year)

Earnings for Medifast (MED)

Earnings in 2025 (TTM): -A$8.68 Million

According to Medifast's latest financial reports the company's current earnings are A$0.42 Billion. In 2024 the company made an earning of A$4.35 Million a decrease over its 2023 earnings that were of A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Medifast from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$8.68 Million-298.99%
2024 A$4.35 M-97.72%
2023 A$0.19 B-31.61%
2022 A$0.27 B-14.56%
2021 A$0.32 B61.25%
2020 A$0.20 B47.36%
2019 A$0.13 B31.82%
2018 A$0.10 B74.26%
2017 A$60.01 M47.56%
2016 A$40.67 M-6.36%
2015 A$43.43 M-16.28%
2014 A$51.88 M2%
2013 A$50.86 M44.4%
2012 A$35.22 M-16.75%
2011 A$42.31 M-12.14%
2010 A$48.16 M63.85%
2009 A$29.39 M136.71%
2008 A$12.41 M35.74%
2007 A$9.14 M-142.56%
2006 -A$21.5 Million-448.43%
2005 A$6.16 M35.62%
2004 A$4.54 M-16.51%
2003 A$5.44 M
2000 A$0.73 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.25 Billion 2,697.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
-A$16.72 Million 93.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
A$0.12 B-1,550.26%๐Ÿ‡บ๐Ÿ‡ธ USA